• NEUVOGEN Announces Appointment of Chief Financial Officer

    1 month ago - By San Diego Biotechnology

    SAN DIEGO: SAN DIEGO, Dec. 21, 2021 /PRNewswire/ - NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee corporate finance, partnership strategy, and capital markets relationships. "George is a highly respected biotechnology leader and brings a proven track record...
    Read more ...